Holomua Holomua! Ua komo ka lāʻau pale DC mua loa o Kina i hoʻolālā ʻia no ka EBV i nā hoʻokolohua lapaʻau, e lawe mai ana i ka manaʻolana hou i nā poʻe maʻi me nā ʻōpū hematologic.

I kēia mau lā iho nei, ua ʻāpono kūhelu ke Kikowaena no ka Loiloi Lāʻau Lapaʻau (CDE) o ka China National Medical Products Administration i ka inikini KSD-101, i hoʻomohala ʻia e Kousai, e komo i nā hoʻokolohua lapaʻau. ʻAʻole wale kēia ka lāʻau pale dendritic cell mua (DC vaccine) ma Kina e loaʻa ka ʻae ʻia e ka FDA IND akā ʻo ka mea mua hoʻi o kona ʻano ma Kina e hāʻawi ʻia i ka Fast Track Designation (FTD) e ka US Food and Drug Administration. Hōʻike kēia hanana koʻikoʻi i kahi au hou i ka immunotherapy pilikino no nā puʻupuʻu hematologic e pili ana i ka EBV.

ʻO KSD-101 ka lāʻau pale DC autologous mua i hoʻomohala ʻia e Kousai Biotechnology ma muli o kāna kahua ʻenehana "Eco-DC Vax" i hoʻomohala ponoʻī ʻia, a ʻo ia ka huahana lāʻau pale DC mua ma Kina i loaʻa ka ʻae ʻia e ka FDA IND. ʻO kāna ʻano hana e pili ana i ka hoʻomākaukau ʻana i kahi lāʻau pale therapeutic pilikino ma ka hōʻiliʻili ʻana i nā cell mononuclear ponoʻī o ka mea maʻi, e hoʻoikaika iā lākou e hoʻokaʻawale i nā cell dendritic in vitro, a hoʻouka iā lākou me nā antigens paʻakikī e pili ana i ka EBV. Ma hope o ka hoʻokomo hou ʻia ʻana o ka lāʻau pale i loko o ke kino o ka mea maʻi, hiki iā ia ke hoʻāla pololei a hoʻomaʻamaʻa i ka ʻōnaehana pale o ka mea maʻi e ʻike a pepehi i nā cell tumor e hōʻike ana i nā antigens EBV, me ka hoʻokumu ʻana i ka hoʻomanaʻo pale anti-tumor lōʻihi.

### ʻIkepili Lapaʻau Kupaianaha: Nā Hōʻike Mua o ka Palekana a me ka Pono

Ua hōʻoia mua ʻia ka hiki o KSD-101 i nā haʻawina lapaʻau mua. Ma kahi haʻawina lapaʻau Phase I o KSD-101 ma ke ʻano he monotherapy no nā puʻupuʻu hematologic e pili ana i ka EBV i hoʻihoʻi ʻia a paʻakikī hoʻi, ua hōʻea ka helu pane pahuhopu (ORR) i 91.67%, me ka helu hoʻomaha piha (CR) o 83.33% a me ka helu kaohi maʻi (DCR) o 100%. Ua hōʻike pū ka lāʻau i nā pane paʻa a me kahi ʻano palekana maikaʻi. Hāʻawi kēia ʻikepili groundbreaking i ke kākoʻo ikaika no ka waiwai lapaʻau o KSD-101.

### No ke aha e koho ai iā Kina no nā lāʻau lapaʻau ʻoi loa?

Ke holomua wikiwiki nei ʻo Kina i ka noiʻi lapaʻau a me ka hoʻohana ʻana i nā kahua ʻoi loa e like me ka cell therapy a me ka immunotherapy. Ua hoʻolaʻa ʻia ka International Department of Beijing South Region Oncology Hospital no ka hoʻopili ʻana i nā maʻi honua me nā ʻenehana lapaʻau hou loa a me nā manawa hoʻokolohua lapaʻau. ʻO ka holomua wikiwiki o KSD-101 ma Kina ʻo ia hoʻi, hiki i nā maʻi honua ke loaʻa mua i kēia lāʻau lapaʻau kipi.

### E Hoʻokaʻaʻike Mai iā Mākou no ka ʻIke Hou Aku a i ʻole e Loiloi i ke Kūpono

Inā ʻoe a i ʻole kahi mea aloha i hoʻopilikia ʻia e nā ʻōpū hematologic e pili ana i ka EBV (e like me ka lymphoma refractory to standard treatment a i ʻole CAEBV) a makemake ʻoe i ka breakthrough therapy KSD-101, ke kono aku nei mākou iā ʻoe e hoʻokaʻaʻike aku i ka International Department of Beijing South Region Oncology Hospital. E hāʻawi kā mākou hui lapaʻau honua i nā kūkākūkā ʻoihana, nā loiloi moʻolelo lapaʻau, a kōkua i ka hoʻoholo ʻana i ke kūpono no ke komo ʻana i nā hoʻokolohua lapaʻau e hiki mai ana.

E ʻoluʻolu e hoʻokaʻaʻike koke mai iā mākou ma o kēia mau ala:
Kelepona: 400-880-3716
WeChat: 17801183037
Email: 100085_010@163.com | myimmnet@163.com (backup)

Ua maopopo iā mākou ʻo kēlā me kēia manawa lapaʻau he mea ia o ke ola a me ka manaʻolana. Ua kūpaʻa ka ʻOihana Honua o ka Halemai Oncology Hema o Beijing i ka hoʻopili ʻana i ka hakahaka ma waena o nā mea maʻi a me ka ʻenehana lapaʻau hou loa me ka ʻike loea a me ka mālama aloha. E nānā kākou i mua a hana pū e lanakila ai i ka maʻi.

**Ke Keʻena Hoʻokele o ka Halemai Oncology o ka ʻĀpana Hema o Beijing**
Kelepona: 400-880-3716
WeChat: 17801183037
Email: 100085_010@163.com / myimmnet@163.com